Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis

被引:37
|
作者
Sharief, MK [1 ]
Semra, YK [1 ]
机构
[1] Guys Hosp, Dept Neuroimmunol, Guys Kings & St Thomas Sch Med, London SE1 9RT, England
关键词
multiple sclerosis; cerebrospinal fluid; intrathecal; apoptosis; survivin;
D O I
10.1016/S0165-5728(01)00389-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The perpetuation of the inflammatory process in multiple sclerosis (MS) may arise from the failure to eliminate potentially pathogenic autoreactive lymphocytes by programmed cell death (apoptosis). Such impairment may be caused by multiple abnormalities of apoptosis regulatory proteins. In this study, we investigated the expression of survivin, a recently described cell cycle-regulated antiapoptosis protein, in lymphocytes from patients with active relapsing-remitting MS and appropriate controls. Survivin reactivity was detected in intrathecal lymphocytes from some MS patients, but not in resting peripheral lymphocytes. However, mitogen stimulation of resting lymphocytes induced survivin expression, which was significantly higher in stimulated intrathecal and peripheral T lymphocytes from MS patients when compared to controls. In contrast, cellular expression of the antiapoptosis protein Bcl-2 was relatively similar between MS patients and the control groups. Moreover, heightened survivin expression in MS patients correlated with T lymphocyte resistance to apoptosis, and was independent of cellular expression of the death receptor Fas. These findings suggest that upregulation of the antiapoptotic protein survivin in mitogen-stimulated T lymphocytes is a feature of multiple sclerosis. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:358 / 364
页数:7
相关论文
共 50 条
  • [1] Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis
    Sharief, MK
    Noori, MA
    Douglas, MR
    Semra, YK
    EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (05) : 503 - 510
  • [2] ACTIVATED LYMPHOCYTES-T IN PATIENTS WITH MULTIPLE-SCLEROSIS
    GOLAZ, J
    STECK, A
    MORETTA, L
    NEUROLOGY, 1983, 33 (10) : 1371 - 1373
  • [3] Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis
    Sharief, MK
    Semra, YK
    JOURNAL OF NEUROIMMUNOLOGY, 2001, 119 (02) : 350 - 357
  • [4] ACTIVATED LYMPHOCYTES-T IN PATIENTS WITH MULTIPLE-SCLEROSIS IN CLINICAL REMISSION
    KONTTINEN, YT
    BERGROTH, V
    KINNUNEN, E
    NORDSTROM, D
    KOURI, T
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1987, 81 (2-3) : 133 - 139
  • [5] Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis
    Sharief, MK
    Semra, YK
    ARCHIVES OF NEUROLOGY, 2002, 59 (07) : 1115 - 1121
  • [6] Differential in vitro expression of trkB neurotrophin receptor in T lymphocytes from patients with multiple sclerosis
    De Santi, L
    Cantalupo, L
    Cioni, C
    Annunziata, R
    JOURNAL OF NEUROLOGY, 2005, 252 : 112 - 112
  • [7] Abnormal response to glutamate of T lymphocytes from multiple sclerosis patients
    Lombardi, G
    Miglio, G
    Canonico, PL
    Naldi, P
    Comi, C
    Monaco, F
    NEUROSCIENCE LETTERS, 2003, 340 (01) : 5 - 8
  • [8] Subpopulations of T-lymphocytes in patients with multiple sclerosis
    Praksova, P.
    Mikulkova, Z.
    Stourac, P.
    Michalek, J.
    Bednarik, J.
    JOURNAL OF NEUROLOGY, 2010, 257 : S223 - S223
  • [9] Expression of K+ channels by CD4+ T-lymphocytes from multiple sclerosis patients
    Sarchielli, P
    Greco, L
    Candeliere, A
    Floridi, A
    Floridi, A
    Capocchi, G
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 187 - 187
  • [10] PROTO-ONCOGENE EXPRESSION IN LYMPHOCYTES FROM PATIENTS WITH MULTIPLE-SCLEROSIS
    MARTINEY, JA
    BROSNAN, CF
    BERMAN, JW
    ANNALS OF NEUROLOGY, 1988, 24 (03) : 474 - 474